Organon & Co (OGN) USD0.01

Sell:$8.86Buy:$9.04$0.27 (3.08%)

Prices delayed by at least 15 minutes
Sell:$8.86
Buy:$9.04
Change:$0.27 (3.08%)
Prices delayed by at least 15 minutes
Sell:$8.86
Buy:$9.04
Change:$0.27 (3.08%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 May 2025
Carrie Smith CoxChairman of the Board
Buy
Regular purchase transaction
12,469$8.07$100,591.1612,469
7 May 2025
Aaron FalcioneGroup Director
Buy
Regular purchase transaction
5,500$8.77$48,235.0062,974
6 May 2025
Kirke WeaverCompany Secretary
Buy
Regular purchase transaction
8,045$9.21$74,054.2352,489
6 May 2025
Daniel Jeremy KarpExecutive Vice President
Buy
Regular purchase transaction
3,500$8.24$28,828.1046,669
5 May 2025
Kevin AliCEO
Buy
Regular purchase transaction
34,000$8.81$299,370.00282,731
5 May 2025
Matthew M WalshCFO
Buy
Regular purchase transaction
11,400$8.82$100,548.00144,484
31 March 2025
Kevin AliCEO
Sell
Tax related
11,875$14.51$172,306.25248,731
31 March 2025
Kevin AliCEO
Sell
Tax related
21,553$14.51$312,734.03239,134
31 March 2025
Kevin AliCEO
Sell
Tax related
26,964$14.51$391,247.64221,713
31 March 2025
Matthew M WalshCFO
Sell
Tax related
3,819$14.51$55,413.69133,084

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 February 2025
Kevin AliCEO
Sell
Tax related
46,575$14.92$694,899.00182,535
31 March 2025
Kevin AliCEO
Sell
Tax related
26,964$14.51$391,247.64221,713
31 March 2025
Kevin AliCEO
Sell
Tax related
21,553$14.51$312,734.03239,134
5 May 2025
Kevin AliCEO
Buy
Regular purchase transaction
34,000$8.81$299,370.00282,731
3 September 2024
Kevin AliCEO
Sell
Tax related
11,927$20.35$242,714.45144,888

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.